Linda Chavez was just 34 when she discovered she had advanced lung cancer, also called Metastatic Bronchial Carcinoma. A ...

Calidi Biotherapeutics continues to advance its clinical-stage, off-the-shelf, virotherapies. With RTNova, the company is planning multi-modal systemic antitumor virotherapies that can disrupt tumor ...

At the April Sampson Cancer Center on Monday, Tom Uhlman shared his story as part of the Shine a Light on Lung Cancer ...

Certain characteristics of the COVID-19 infection were associated with possible tumor shrinkage in patients with metastatic sites of melanoma, lung, breast and colon cancers, an expert told CURE®.

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 ... Scientists Discover That ...

The four most common sites for metastases are the bones, lungs, liver, and brain. Metastases can complicate the systemic symptoms of advanced breast cancer, including fatigue, nausea, loss of ...

The FDA has approved FoundationOne Liquid CDx as a companion diagnostic for patients with metastatic non–small cell lung ...

When treating brain metastases in patients with non–small cell lung cancer (NSCLC), brain radiotherapy has been the standard option. However, a growing body of evidence indicates that immunotherapy ...

Calidi (CLDI) Biotherapeutics presented data at the International Oncolytic Virotherapy Conference and the Society for Immunotherapy of Cancer Annual Meeting to support the targeted capabilities of ...